Skip to content

Insider · CIK 0001274139

Robert Hershberg

directorofficer

Files at ADPT (Adaptive Biotechnologies Corp), RXRX (RECURSION PHARMACEUTICALS, INC.), HLVX (HilleVax, Inc.), ATAI (AtaiBeckley Inc.). First filing Feb 12, 2025, latest Oct 7, 2026.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $576k sold

Where the trades landed

Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.

RXRX: RECURSION PHARMACEUTICALS, INC.

RXRXOct 9, 2026 · close 4.36

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

ADPT: Adaptive Biotechnologies Corp

ADPTOct 9, 2026 · close 26.49

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
3Weak
RXRXsell 210b5-1
RECURSION PHARMACEUTICALS, INC.
$125k
25,000 shares
-13%+63% from low-32% from high
56Moderate
ADPTsell 10
Adaptive Biotechnologies Corp
$402k
53,000 shares
-43%+91% from low-11% from high
30Weak
HLVXsell 2
HilleVax, Inc.
$49k
26,535 shares
-2%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Oct 6, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
MOption exercise
Class A Common Stock10b5-1
+25,000$2.22$56k187,1565 d ago
Oct 6, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
SOpen-market sale
Class A Common Stock10b5-1
-25,000$5.00$125k162,1565 d ago
Oct 6, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-25,000$2.22$56k500,0005 d ago
Sep 11, 2026ATAI
AtaiBeckley Inc.
DDisposition to issuer
Stock Optionderivative
-48,858--031 d ago
Sep 11, 2026ATAI
AtaiBeckley Inc.
DDisposition to issuer
Stock Optionderivative
-404,869--031 d ago
Sep 11, 2026ATAI
AtaiBeckley Inc.
DDisposition to issuer
Stock Optionderivative
-62,394--031 d ago
Sep 11, 2026ATAI
AtaiBeckley Inc.
DDisposition to issuer
Stock Optionderivative
-103,000--031 d ago
Sep 11, 2026ATAI
AtaiBeckley Inc.
DDisposition to issuer
Stock Optionderivative
-121,968--031 d ago
Jun 18, 2025RXRX
RECURSION PHARMACEUTICALS, INC.
AGrant or award
Class A Common Stock
+22,016$0.00$073,732Jun 23, 2025
Jun 18, 2025RXRX
RECURSION PHARMACEUTICALS, INC.
AGrant or award
Stock Option (Right to Buy)derivative
+44,031$0.00$044,031Jun 23, 2025
Mar 12, 2025ADPT
Adaptive Biotechnologies Corp
SOpen-market sale
Common Stock
-53,000$7.59$402k69,690Mar 12, 2025
Mar 4, 2025ADPT
Adaptive Biotechnologies Corp
AGrant or award
Common Stock
+15,394$0.00$0122,690Mar 6, 2025
Mar 4, 2025ADPT
Adaptive Biotechnologies Corp
AGrant or award
Stock Option (right to buy)derivative
+23,726$0.00$023,726Mar 6, 2025
Feb 4, 2025HLVX
HilleVax, Inc.
SOpen-market sale
Common Stock
-14,634$1.89$28k1,113,399Feb 12, 2025
Feb 11, 2025HLVX
HilleVax, Inc.
SOpen-market sale
Common Stock
-11,901$1.76$21k1,101,498Feb 12, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Robert Hershberg: insider trades and track record | InsiderTell